227 studies found for:    "Parkes Weber syndrome" OR "Vascular Malformations"
Show Display Options
Rank Status Study
21 Completed Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome
Condition: Sturge- Weber Syndrome
Intervention: Drug: Drug: Topical Rapamycin
22 Completed Biomarker Development in Sturge-Weber Syndrome
Condition: Sturge-Weber Syndrome
Intervention:
23 Completed
Has Results
Long-term Effects of Thalidomide for Recurrent Gastrointestinal Bleeding Due to Vascular Malformation
Conditions: Obscure Gastrointestinal Bleeding;   Angiodysplasia;   Gastric Antral Vascular Ectasia;   Thalidomide
Interventions: Drug: Thalidomide;   Drug: Iron
24 Recruiting Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS
Conditions: Brain Injury;   Central Nervous System Degenerative Disorder;   Central Nervous System Infectious Disorder;   Central Nervous System Vascular Malformation;   Hemorrhagic Cerebrovascular Accident;   Ischemic Cerebrovascular Accident;   Primary Brain Neoplasm;   Brain Cancer;   Brain Tumors
Interventions: Drug: Ferumoxytol;   Other: Tissue Analysis;   Procedure: Magnetic Resonance Imaging
25 Recruiting AVAST Anomalies Vasculaires Associées au Syndrome de Turner (Vascular Abnormalities Associated With Turner Syndrome)
Conditions: Turner Syndrome;   Peripheral Angiopathy;   Vascular Malformation;   Lymphedema
Intervention: Procedure: Echo doppler
26 Active, not recruiting Bone Health in Patients With Overgrowth
Conditions: Bone Mineral Density;   Vascular Malformations
Intervention:
27 Recruiting Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anaemia Due to Small Bowel Angiodysplasias
Conditions: Angiodysplasia;   Vascular Malformations;   Gastrointestinal Hemorrhage;   Anemia
Intervention: Drug: Octreotide
28 Enrolling by invitation The Management of Postoperative Craniotomy Pain in Pediatric Patients
Conditions: Post Craniotomy Surgery;   Cancer;   Epilepsy;   Vascular Malformations;   Craniofacial Reconstructive Surgery
Intervention:
29 Completed Estimation of the Placental Volume by 3D Ultrasound at 12, 16 and 22 Weeks : Relation With Growth Factors and D-Dimers
Condition: Placenta Vascular Malformation
Intervention: Other: blood sample
30 Completed Efficacy and Safety of the Mammalian Target of Rapamycin (mTor Rapamycin) Inhibitor in Vascular Malformations
Condition: Cardiovascular Abnormalities
Intervention: Drug: Sirolimus
31 Completed Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
32 Active, not recruiting Genetic Basis of Hemangiomas
Condition: Hemangioma, Vascular Anomalies
Interventions: Genetic: Cheek cell samples or blood sample (4mL);   Genetic: Cheek cell sample or blood sample (4mL)
33 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
34 Completed Phase I Drug Trial for S/E of Marimastat in Disabling Malformations When no Other Options.
Condition: Vascular Anomalies
Intervention: Drug: Marimastat
35 Active, not recruiting ONYX Evaluation in the Endovascular Treatment of Intracranial Dural Arteriovenous Fistulae
Condition: Arteriovenous Fistula
Intervention:
36 Completed Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks: Comparison of 577 nm Versus 595 nm Wavelengths
Condition: Port Wine Stains
Interventions: Other: Pulsed Dye Laser 577 nm;   Other: Pulsed Dye Laser 595 nm
37 Completed
Has Results
Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
Condition: Port Wine Stains
Intervention: Drug: Combined Photodynamic & Pulsed Dye Laser Treatment
38 Recruiting Treatment of Brain AVMs (TOBAS) Study
Conditions: Unruptured Brain Arteriovenous Malformation;   Ruptured Brain Arteriovenous Malformation;   Arteriovenous Malformations;   AVM;   BAVM
Interventions: Procedure: Neurosurgery;   Radiation: Radiation therapy;   Procedure: Embolization
39 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia (HHT).
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
40 Completed Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Tranexamic acid first, than placebo;   Drug: First placebo, than Tranexamic acid.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years